Bico's Biosero Secures Major Contract Worth 143.6 Million SEK
Bico's subsidiary Biosero has secured a 143.6 million SEK contract with a global pharmaceutical firm.
- • Biosero signed a framework agreement in August 2025.
- • First purchase orders total 15.2 million dollars.
- • Contract highlights Bico's growth in laboratory automation.
- • Announcement made via press release.
Key details
Biosero, a subsidiary of Bico, has landed a significant framework agreement with a prominent global pharmaceutical company. Announced on September 5, 2025, the deal showcases Biosero's growing footprint in integrated laboratory automation solutions. Initially, this agreement has led to purchase orders aggregating approximately 15.2 million dollars, which is around 143.6 million Swedish kronor. This development signals Bico's capability to attract lucrative contracts within the competitive pharmaceutical industry, reinforcing the importance of its operations in the biotechnology sector.
This article was translated and synthesized from Swedish sources, providing English-speaking readers with local perspectives.
Source articles (1)
Latest news
Sweden Democrats' 'Quisling' Remarks Ignite Political Tensions During Campaign
Foxtrot Gang Leaders Sentenced to Life in Iraq; Extradition Challenges Loom for Sweden
Sweden Withdraws Support for FIFA President Infantino Amid World Cup Share Controversy; European Athletics Events Broadcast in Sweden
Luleå's Education Debate: New High School vs. Strategic School Consolidations
Swedish Political Parties Unite on Need to Increase Shooting Ranges Amid Hunting Debate
Sweden Criticizes Spain's Migration Policy Amid 2026 Ceuta Crisis
The top news stories in Sweden
Delivered straight to your inbox each morning.